Circulomics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $29.6M

Circulomics General Information

Description

Developer of a single molecule analysis system designed to perform cancer analysis and diagnosis. The company's system streamlines every step in the genomics workflow from sample preparation to assays and detection instruments, enabling researchers to better characterize their samples before costly sequencing or critical studies.

Contact Information

Website
www.circulomics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 701 East Pratt Street
  • Unit G01
  • Baltimore, MD 21202
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Pacific BioSciences of California
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 701 East Pratt Street
  • Unit G01
  • Baltimore, MD 21202
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Circulomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 20-Jul-2021 $29.6M Completed Generating Revenue
5. Grant 01-Jan-2020 Completed Generating Revenue
4. Grant 01-Jan-2017 Completed Generating Revenue
3. Grant 01-Jan-2014 Completed Generating Revenue
2. Grant 10-Dec-2012 $874K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Circulomics’s complete valuation and funding history, request access »

Circulomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a single molecule analysis system designed to perform cancer analysis and diagnosis. The company's system s
Other Pharmaceuticals and Biotechnology
Baltimore, MD
10 As of 2021

Aliso Viejo, CA
 

Montreal, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Circulomics Competitors (11)

One of Circulomics’s 11 competitors is Ambry Genetics, a Formerly PE-Backed company based in Aliso Viejo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ambry Genetics Formerly PE-Backed Aliso Viejo, CA
Cyclenium Pharma Corporate Backed or Acquired Montreal, Canada
Horizon Discovery Formerly VC-backed Cambridge, United Kingdom
Asuragen Formerly VC-backed Austin, TX
Gene By Gene Formerly VC-backed Houston, TX
You’re viewing 5 of 11 competitors. Get the full list »

Circulomics Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • Pending

  • Expiring in next 12 mo

Circulomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021119425-A1 Rapid precipitation-driven kilobase size selection of hmw dna Inactive 13-Dec-2019
WO-2019006321-A1 Size selection purification using a thermoplastic silica nanomaterial Inactive 30-Jun-2017
JP-2022169782-A Size-selective purification using thermoplastic silica nanomaterials Active 30-Jun-2017
EP-3250690-A1 Hierarchical silica lamella for magnetic nucleic acid extraction Active 27-Jan-2015
EP-3250690-A4 Hierarchical silica lamella for magnetic nucleic acid extraction Active 27-Jan-2015 B03C1/30
To view Circulomics’s complete patent history, request access »

Circulomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Circulomics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Johns Hopkins Technology Ventures Accelerator/Incubator
National Institute of Environmental Health Sciences Government
National Institute of General Medical Sciences Government
TEDCO Venture Capital Minority
The National Human Genome Research Institute Government
To view Circulomics’s complete investors history, request access »

Ready to get started?

Request a free trial

Circulomics FAQs

  • When was Circulomics founded?

    Circulomics was founded in 2009.

  • Where is Circulomics headquartered?

    Circulomics is headquartered in Baltimore, MD.

  • What is the size of Circulomics?

    Circulomics has 10 total employees.

  • What industry is Circulomics in?

    Circulomics’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Circulomics a private or public company?

    Circulomics is a Private company.

  • What is the current valuation of Circulomics?

    The current valuation of Circulomics is .

  • What is Circulomics’s current revenue?

    The current revenue for Circulomics is .

  • Who are Circulomics’s investors?

    Johns Hopkins Technology Ventures, National Institute of Environmental Health Sciences, National Institute of General Medical Sciences, TEDCO, and The National Human Genome Research Institute have invested in Circulomics.

  • Who are Circulomics’s competitors?

    Ambry Genetics, Cyclenium Pharma, Horizon Discovery, Asuragen, and Gene By Gene are some of the 11 competitors of Circulomics.

  • When was Circulomics acquired?

    Circulomics was acquired on 20-Jul-2021.

  • Who acquired Circulomics?

    Circulomics was acquired by Pacific BioSciences of California.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process